OYAMADA, H., TABEI, T., YONEYAMA, T., EOUCHI, K., ORII, H. and TERUI, S. Whole Body Bone Scintigram and Stage Classification of the Patients with Adenoear cinoma of Lung. Tohoku J. exp. Med., 1978, 124 (2),145-151 -One hundred and six patients having adenocarcinoma of the lung were studied by whole body bone scanning with 99mTc-phosphates in connection with their clinical stages. Abnormal accumulation was found in 64 patients (60%). There were 64 patients who received surgical treatment.
Among these 64 patients, 38 underwent bone scanning within 3 months after the establishment of their clinical stages. Twenty-two of them were classified as Stage I clinically.
Pathological stage classification after the surgery revealed these 22 to be classified into 3 groups; 6 for Pathological Stage for the second one to present distant metastases even when the primary lesi noted on the X-ray film is still small. Although the third one also has similar terulency, it is encountered less frequently than the second one. These facts sometimes make us difficult to determine clinical stages of cases of lung cancer of this partic ular type. This is to report our results of whole body bone scintigram in patients with adenocarcinoma of the lung and to evaluate its usefulness for the clinical staging.
MATERIALS AND METHODS
The patients subjected to this study were cases which underwent whole body bone scanning with 99mTe-phosphates because of adenocarcinoma of the lung at the National Cancer Center, Tokyo, from the end of 1972 through September, 1976. All of them have been histologically verified on the specimens obtained either transbronchially or surgically.
These cases consist of 68 males and 38 females and the average ages were 60.7 and 56.6, respectively. Technetium-99m phosphates used were polyphosphates initially and later pyrophosphates, but diphosphonate has been used for the past 3 years. The dose injected was 15 mCi as a rule. Scan was started approximately 2 hr after the injection for the whole body imaging of 1/5 size, and at least thoracic and lumbar vertebrae as well as pelvic bones were rescanned for 1/1 size images afterwards. If necessary, spot scintigrams by scinticamera were taken also.
The stage classification was based on UICC (Union Internationale Contre le Cancer) proposal.
RESULTS
There were 106 patients as a total and the stage classification is shown in Table 1 . Sixty-four out of 106 (60%) were found to have hot spots somewhere in the body. As the disease progressed scan-positive cases increased. However, this table summarized all the patients on whom bone scan was performed no matter how the interval between the time of clinical diagnosis and the time of scan was. Therefore, only the cases on which surgical treatment was performed and on which scintigram was taken within 3 months following the clinical diagnosis were selected and were summarized in Table 2 . There were 38 such cases, 13 of which were scan-positive. Among 22 cases of Clinical Stage I, 7 were scan-positive. These 22 were further evaluated on the basis of surgical and pathological findings as seen in Table 3 It is a well known fact that scan-positive does not necessarily mean bone metastasis. Therefore, when a hot spot was found in the rib (Fig. 1) we put our effort to confirm it by the needle biopsy method. There were 5 such cases so far, which were summarized in Table 7 . All of these 5 cases were proved to have rib metastases at the areas of radioisotope accumulation. Table 8 indicates the areas where hot spots were found in the patients of Clinical Stage I, who were treated surgically. Thoracic spine, lumbar spine and rib were the sites of the most frequent occurrence of metastases from the carcinoma of this type.
DISCUSSION
Bone scanning has been already noted as a useful technique in detecting bone metastases even in the early days with 85Sr (Charkes and Sklaroff 1964 Subramanian et al. 1972 Subramanian et al. , 1975a Subramanian et al. , 1975b .
These phosphates are equally capable of visualizing the sites of bone metastasis as well as some benign conditions as a hot spot just like the former radiopharmaceuticals are (Thrall et al. 1973; Oyamada et al. 1976 ).
Therefore, diagnosis of bone metastasis cannot be established on the basis of scintigram findings alone. To solve this undesirable problem bone biopsy is recommended, which has been performed in our group when hot spots are noted in the rib. If questionable findings are present scan should be repeated at a certain interval with careful x-ray survey. As mentioned in the previous report (Oyamada et al. 1975 ), the bone image in the thorax after thoracic surgery brings us some confusion. Therefore, we excluded such findings in that area in the series of this study. Asymmetrical accumulations of a mild degree in joints were also excluded unless radiological verifications were made. Although there exist such problems in interpreting the bone scintigrams, it is now an indispensable technique for the diagnosis of bone metastasis. Already many papers have been published, referring to the superiority of bone scanning over the conventional x-ray survey for detecting bone metastases.
According to McCormick et al. (1975) , 72 out of 162 patients with breast cancer showed positive bone scintigrams with 87mSr and in 63 of these 72 the accumulations were confirmed to be metastases afterwards. Krishnamurthy and Blahd (1975) reported the results of bone scanning with 99mTc-polyphosphate , mentioning this technique to be more valuable in comparison with the values of serum calcium and phosphorus which were not so certain.
Taking all the patients tested by bone scanning no matter how their clinical stages are, Tofe et al. (1975) reported, in their large series of scinti-survey, ratio of bone metastases of breast cancer to be 67% and that of lung cancer 64%. They also mentioned, for the lung cancer, that the thorax to be the commonest site of bone metastases (95 out of 147 scan-positive patients), secondly vertebrae (63/147), and thirdly extremities (47/147). Of 41 patients in Clinical Stage I of our series who were treated surgically, 12 showed metastases to thoracic vertebrae, 11 to lumbar vertebrae, 9 to ribs and 5 to extremities. These results support the usefulness of bone scintiscanning in cases of lung cancer because it is sometimes difficult to find out metastatic lesions in the rib and the thoracic vertebra with x-ray.
In the field of cancer therapy, presence or absence of bone metastasis c n be a critical point at the time for establishing the therapeutic regimen. In this regard, the whole body bone scintigram would be very important for the stage classification of malignant disease, as already suggested by others (Hansen and Muggia 1972; Tofe et al. 1975 ). Cases of adenocarcinoma of the lung are thought to be worthy of attention. Among the 22 patients who were originally classified as Stage I clinically, only 6 were found to belong to Pathological Stage I after the surgery. Four were placed into Stage ‡U and the remaining 12 were Stage ‡V.
It is interesting that none of the above-mentioned 6 patients in Pathological Stage I showed abnormal scintigrams while 1 of 4 patients (25%) in Pahological Stage ‡U and 6 of 12 patients (50%) in Pathological Stage ‡V were found abnormal. Therefore, if the results of the whole body bone scintigrams had been taken into consideration for the clinical stage classification, at least 7 of the 22 patients (32%) would have been placed into more advanced stages and could be expected to receive more proper treatment instead of surgical therapy.
Thus, the application of bone scintigram to clinical stage classification for the cases of adenocarcinoma of the lung is now strongly recommended .
